← MADRIGAL PHARMACEUTICALS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $19.1m | $148.6m | $57.4m | $46.7m | $54.0m | $36.3m | $331.5m | $99.9m | $100.0m | $198.7m | |
| Prepaid Expense and Other Assets, Current | $708k | $485k | $1.5m | $1.2m | $1.0m | $1.3m | $2.6m | $3.1m | $13.8m | $47.8m | |
| Cash, Cash Equivalents, and Short-term Investments | — | — | — | — | — | — | — | $634.1m | $931.3m | — | |
| Inventory, Net | — | — | — | — | — | — | — | $0 | $34.1m | $74.8m | |
| Assets, Current | $41.2m | $192.0m | $485.2m | $440.2m | $285.2m | $271.7m | $361.4m | $637.3m | $1.0b | $1.2b | |
| Property, Plant and Equipment, Net | $3k | $301k | $227k | $1.2m | $1.0m | $851k | $601k | $1.6m | $2.2m | $1.5m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $675k | $785k | $797k | $602k | $1.7m | $2.4m | $4.9m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | — | — | — | $53.8m | $134.5m | |
| Accrued Liabilities, Current | $4.0m | $8.1m | $6.0m | $23.6m | $45.2m | $55.0m | $91.5m | $90.0m | $124.7m | $260.4m | |
| Assets | $41.2m | $192.3m | $485.4m | $442.1m | $287.0m | $273.3m | $362.6m | $640.5m | $1.0b | $1.3b | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $315k | $318k | $410k | $602k | $527k | $983k | $1.0m | |
| Accounts Payable, Current | $762k | $1.9m | $2.5m | $1.2m | $1.0m | $21.4m | $23.8m | $28.0m | $43.6m | $48.9m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $361k | $468k | $387k | $0 | $1.2m | $1.0m | $6.7m | |
| Long-term Debt, Excluding Current Maturities | — | — | — | — | — | — | $49.3m | $115.5m | $117.6m | $339.9m | |
| Liabilities, Current | $4.8m | $10.1m | $8.4m | $25.1m | $46.6m | $76.8m | $115.9m | $118.5m | $169.3m | $310.3m | |
| Liabilities | $4.8m | $10.1m | $8.4m | $25.5m | $47.0m | $77.2m | $165.2m | $235.2m | $287.9m | $656.9m | |
| Stockholders’ equity: | |||||||||||
| Preferred Stock, Value, Issued | $1k | $1k | $2k | $2k | $2k | $2k | $0 | $0 | $0 | $0 | |
| Common Stock, Value, Issued | $1k | $1k | $2k | $2k | $2k | $2k | $2k | $2k | $2k | $2k | |
| Retained Earnings (Accumulated Deficit) | ($75.3m) | ($106.5m) | ($139.3m) | ($223.2m) | ($425.5m) | ($667.3m) | ($962.7m) | ($1.3b) | ($1.8b) | ($2.1b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $25k | ($31k) | ($319k) | $216k | $47k | ($80k) | ($32k) | $468k | $468k | $873k | |
| Additional Paid in Capital, Common Stock | $111.7m | $288.8m | $616.6m | $639.6m | $665.4m | $863.5m | $1.2b | $1.7b | $2.6b | $2.7b | |
| Stockholders' Equity Attributable to Parent | $36.4m | $182.3m | $477.0m | $416.6m | $240.0m | $196.1m | $197.4m | $405.3m | $754.4m | $602.7m | |
| Liabilities and Equity | $41.2m | $192.3m | $485.4m | $442.1m | $287.0m | $273.3m | $362.6m | $640.5m | $1.0b | $1.3b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.